Streptozotocin-induced diabetes decreases placenta growth factor (PIGF) levels in rat placenta

The placenta produces several growth factors, including placenta growth factor (PIGF), which are essential for placenta growth and fetal growth. Diabetic pregnancy induces the abnormal placental growth and fetal development. This study investigated whether diabetes in pregnant rats induces changes i...

Full description

Saved in:
Bibliographic Details
Published inJournal of Veterinary Medical Science Vol. 69; no. 9; pp. 877 - 880
Main Authors Koh, P.O.(Gyeongsang National Univ., Jinju (Korea R.)), Sung, J.H, Won, C.K, Cho, J.H, Moon, J.G, Park, O.S, Kim, M.O
Format Journal Article
LanguageEnglish
Published Japan JAPANESE SOCIETY OF VETERINARY SCIENCE 01.09.2007
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The placenta produces several growth factors, including placenta growth factor (PIGF), which are essential for placenta growth and fetal growth. Diabetic pregnancy induces the abnormal placental growth and fetal development. This study investigated whether diabetes in pregnant rats induces changes in PIGF expression in the placenta. Diabetes was induced by a single intravenous injection of streptozotocin (35 mg/kg body weight) on day 0 of pregnancy, blood and tissue samples were collected on day 20 of pregnancy. In the diabetic group, maternal body weight and fetal weight significantly decreased compared to controls. RT-PCR and Western blot analyses showed that expression of PIGF was significantly decreased in placenta by streptozotocin treatment. Immunohistochemical study showed that the positive signal of PIGF in trophoblast cells was decreased in the diabetic group compared to controls. These findings demonstrate the decline of PIGF in the placenta in diabetic pregnancy.
Bibliography:L70
2008003377
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0916-7250
1347-7439
DOI:10.1292/jvms.69.877